LifeMD, Inc. — Director's Dealing 2023

Sep 1, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LifeMD, Inc. (LFMD)
CIK: 0000948320
Period of Report: 2022-11-02

Reporting Person: Velge Bertrand (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-11-22	Common Stock	A	10000	—	Acquired	926666	Indirect
2023-08-29	Common Stock	P	32072	$3.58	Acquired	249482	Indirect
2023-08-30	Common Stock	P	40000	$3.76	Acquired	289482	Indirect
2023-08-31	Common Stock	P	60000	$3.93	Acquired	349482	Indirect

Footnotes

F1: The grant of restricted shares vested incrementally on December 31, 2022 (50%), March 31, 2023 (25%), and June 16, 2023 (25%).

F2: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.54 to $3.60, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the numbers of shares purchased at each separate price with the ranges set forth.

F3: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.86 to $3.99, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the numbers of shares purchased at each separate price with the ranges set forth.